X T L Biopharmaceuticals reported $23.14M in Ordinary Share Capital for its fiscal quarter ending in December of 2024.


Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2K 0 Dec/2024
Bioline Rx USD 2.56B 2.5B Jun/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025
X T L Biopharmaceuticals USD 23.14M 0 Dec/2024